Trademark: 79294807
Word
NUCLERA
Status
Registered
Status Code
700
Status Date
Tuesday, January 25, 2022
Serial Number
79294807
Registration Number
6624194
Registration Date
Tuesday, January 25, 2022
Mark Type
4000
Filing Date
Tuesday, November 19, 2019
Published for Opposition
Tuesday, June 8, 2021

Trademark Owner History
Nuclera Ltd - Original Registrant
Nuclera Nucleics Ltd - Owner At Publication

Classifications
40 Custom manufacture of therapeutic drugs, including therapeutic DNA, RNA, genes and oligonucleotides; manufacture of synthetic DNA, RNA, genes and oligonucleotides for others
9 Scientific research and laboratory apparatus, namely, scientific desktop instruments for gene, RNA and protein synthesis; semiconductors, semiconductor chips, microchips, bio-sensors, bio-chips; scientific research and laboratory apparatus, namely, apparatus for amplifying DNA and RNA, apparatus for manufacturing DNA and RNA, apparatus for processing DNA and RNA; apparatus for recording, transmission or reproduction of data including video, audio, images and text for scientific purposes; data processing equipment and computers; computer hardware; downloadable and recorded computer software for scientific data analysis; downloadable and recorded computer programs for scientific data analysis; data carriers containing scientific data; parts and fittings for all the aforesaid goods
5 Biological, chemical and biochemical reagents, namely, DNA and RNA products, proteins and gene editing enzymes for clinical or medical laboratory use; pharmaceutical and veterinary preparations, namely, nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes; therapeutic DNA and RNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes
1 Chemicals for scientific purposes; chemicals for use in research; chemicals, enzymes, DNA and RNA for research use; chemicals for use in the preparation and creation of DNA and RNA; enzymes for use in the preparation and creation of DNA and RNA; molecular biology research tools in the nature of biological and biochemical reagents; gene editing enzymes
44 Medical and veterinary services; healthcare services; DNA and RNA screening for medical purposes; genetic and blood testing, sequencing and measuring services for medical and health purposes; provision of information relating to the analysis of DNA and RNA for medical and health purposes; providing advice and consultancy in the field of medical and veterinary therapies
10 Medical and veterinary apparatus and instruments namely, apparatus for DNA and RNA analysis, sequencing and synthesis; apparatus for gene, RNA and protein synthesis for medical and veterinary purposes
42 Scientific and technological services, namely , scientific research, structural and functional analysis of genomes and genetic testing and in the fields of genomics, DNA and RNA sequencing, gene synthesis, RNA synthesis, protein synthesis, gene identification, gene cloning, gene expression, gene mapping, and research and design in the field of DNA research and development, gene and protein synthesis; chemical and biological analysis and research services; research into DNA and RNA for scientific purposes; research and development into the creation of DNA and RNA; research, development, scientific testing and analysis in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, gene mapping; scientific research in the field of molecular biology, next generation sequencing, high-throughput sequencing and bioinformatics; gene-editing services for scientific research purposes; DNA and RNA modelling services for scientific purposes; gene engineering services; research and development services in the creation of genome libraries or collections of biologicals including chemicals and compounds; creating libraries or collections of normal and mutated genes for scientific research purposes; electronic data storage services; consultancy and advisory services relating to the aforesaid services

Trademark Events
Jun 15, 2023
Change Of Name/Address Rec'd From Ib
Jul 25, 2022
Final Decision Transaction Processed By Ib
Jun 30, 2022
Final Disposition Notice Sent To Ib
Jun 29, 2022
Final Disposition Processed
Apr 25, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jan 25, 2022
Registered-Principal Register
Dec 17, 2021
Changes/Corrections After Pub Approval Entered
Dec 16, 2021
Extension Of Time To Oppose Process - Terminated
Dec 16, 2021
Assigned To Petition Staff
Dec 1, 2021
Teas Post Publication Amendment Received
Jun 29, 2021
Extension Of Time To Oppose Received
Jun 8, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 8, 2021
Published For Opposition
May 19, 2021
Notification Of Notice Of Publication E-Mailed
May 4, 2021
Approved For Pub - Principal Register
May 4, 2021
Examiner's Amendment Entered
May 4, 2021
Notification Of Examiners Amendment E-Mailed
May 4, 2021
Examiners Amendment E-Mailed
May 4, 2021
Examiners Amendment -Written
Apr 30, 2021
Teas/Email Correspondence Entered
Apr 29, 2021
Correspondence Received In Law Office
Apr 29, 2021
Teas Response To Office Action Received
Nov 22, 2020
Refusal Processed By Ib
Nov 3, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Nov 3, 2020
Refusal Processed By Mpu
Oct 10, 2020
Application Filing Receipt Mailed
Oct 9, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Oct 8, 2020
Non-Final Action Written
Oct 6, 2020
Assigned To Examiner
Oct 6, 2020
New Application Office Supplied Data Entered
Oct 1, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24